ACKB Stock Analysis: Ackermans & Van Haaren | BR
Engineering & Construction | BR, Belgium | Market Cap: 8.290m EUR | 12M Return: 22.9% | BE0003764785 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 6.03M
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ackermans & Van Haaren NV is a Belgium-based diversified holding company with businesses spanning marine engineering and contracting, private banking, real estate, energy and resources, and growth capital. Its marine activities include dredging, civil works on water and offshore projects, including wind farms.
The group also develops property, provides wealth management and financing services, and invests in businesses across areas such as automation, logistics, biogas and medical technology. It was founded in 1876 and is based in Antwerp.
- DEME offshore wind and dredging backlog drives earnings growth
- Private banking AUM growth lifts recurring fee income
- Palm oil prices and sustainability rules pressure SIPEF margins
| Net Income: 658.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -2.46 > 1.0 |
| NWC/Revenue: -44.06% < 20% (prev -46.89%; Δ 2.83% < -1%) |
| CFO/TA 0.05 > 3% & CFO 1.02b > Net Income 658.9m |
| Net Debt (8.24b) to EBITDA (1.29b): 6.39 < 3 |
| Current Ratio: 0.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (32.8m) vs 12m ago 0.17% < -2% |
| Gross Margin: 13.69% > 18% (prev 26.71%; Δ -13.02% > 0.5%) |
| Asset Turnover: 28.46% > 50% (prev 30.04%; Δ -1.58% > 0%) |
| Interest Coverage Ratio: 4.29 > 6 (EBIT TTM 757.9m / Interest Expense TTM 176.7m) |
| A: -0.12 (Total Current Assets 8.01b - Total Current Liabilities 10.6b) / Total Assets 21.3b |
| B: 0.28 (Retained Earnings 5.91b / Total Assets 21.3b) |
| C: 0.04 (EBIT TTM 757.9m / Avg Total Assets 20.9b) |
| D: 0.43 (Book Value of Equity 5.90b / Total Liabilities 13.7b) |
| Altman-Z'' = 0.79 = B |
| DSRI: 0.94 (Receivables 4.49b/4.97b, Revenue 5.96b/6.19b) |
| GMI: 1.95 (GM 26.71% / 13.69%) |
| AQI: 0.99 (AQ_t 0.46 / AQ_t-1 0.47) |
| SGI: 0.96 (Revenue 5.96b / 6.19b) |
| TATA: -0.02 (NI 658.9m - CFO 1.02b) / TA 21.3b) |
| Beneish M = -2.25 (Cap -4..+1) = BBB |
As of November 01, 2026, the stock is trading at EUR 263.20 with a total of 20,904 shares traded. Over the past week, the price has changed by +3.70%, over one month by -1.72%, over three months by -2.52% and over the past year by +22.90%.
Current recommended Stop Loss: 254.70 (which is 3.2% or 1.9 ATR below the current price).
Ackermans & Van Haaren has no consensus analysts rating.
P/E Trailing = 12.6206
P/E Forward = 13.9276
P/S = 1.3913
P/B = 1.483
P/EG = 5.7354
Revenue TTM = 5.96b EUR
EBIT TTM = 757.9m EUR
EBITDA TTM = 1.29b EUR
Long Term Debt = 2.56b EUR (from longTermDebt, last quarter)
Short Term Debt = 7.51b EUR (from shortTermDebt, last quarter)
Debt = 10.5b EUR (from shortLongTermDebtTotal, last quarter) + Leases 230.1m
Net Debt = 8.24b EUR (calculated: Debt 10.5b - CCE 2.24b)
Enterprise Value = 16.5b EUR (8.29b + Debt 10.5b - CCE 2.24b)
Interest Coverage Ratio = 4.29 (Ebit TTM 757.9m / Interest Expense TTM 176.7m)
EV/FCF = 35.99x (Enterprise Value 16.5b / FCF TTM 459.2m)
FCF Yield = 2.78% (FCF TTM 459.2m / Enterprise Value 16.5b)
FCF Margin = 7.71% (FCF TTM 459.2m / Revenue TTM 5.96b)
Net Margin = 11.06% (Net Income TTM 658.9m / Revenue TTM 5.96b)
Gross Margin = 13.69% ((Revenue TTM 5.96b - Cost of Revenue TTM 5.14b) / Revenue TTM)
Gross Margin QoQ = 13.32% (prev 14.07%)
Tobins Q-Ratio = 0.78 (Enterprise Value 16.5b / Total Assets 21.3b)
Interest Expense / Debt = 1.69% (Interest Expense 176.7m / Debt 10.5b)
Taxrate = 16.53% (169.4m / 1.02b)
NOPAT = 632.6m (EBIT 757.9m * (1 - 16.53%))
Current Ratio = 0.75 (Total Current Assets 8.01b / Total Current Liabilities 10.6b)
Debt / Equity = 1.78 (Debt 10.5b / totalStockholderEquity, last quarter 5.90b)
Debt / EBITDA = 6.39 (Net Debt 8.24b / EBITDA 1.29b)
Debt / FCF = 17.93 (Net Debt 8.24b / FCF TTM 459.2m)
Total Stockholder Equity = 5.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.15% (Net Income 658.9m / Total Assets 21.3b)
RoE = 11.85% (Net Income TTM 658.9m / Total Stockholder Equity 5.56b)
RoCE = 9.33% (EBIT 757.9m / Capital Employed (Equity 5.56b + L.T.Debt 2.56b))
RoIC = 3.55% (NOPAT 632.6m / Invested Capital 17.8b)
WACC = 3.81% (E(8.29b)/V(18.8b) * Re(6.85%) + D(10.5b)/V(18.8b) * Rd(1.69%) * (1-Tc(0.17)))
Discount Rate = 6.85% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -86.56 | Cagr: -0.52%
[DCF] Terminal Value 73.10% ; FCFF base≈656.1m ; Y1≈575.4m ; Y5≈464.9m
[DCF] Fair Price = N/A (negative equity: EV 7.46b - Net Debt 8.24b = -773.5m; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 72.51 | Revenue CAGR: 4.86% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=19.62 | Chg30d=+0.46% | Revisions=+40% | GrowthEPS=+5.9% | GrowthRev=+4.4%
EPS next Year (2027-12-31): EPS=20.03 | Chg30d=+0.00% | Revisions=+0% | GrowthEPS=+2.1% | GrowthRev=-3.1%
[Analyst] Revisions Ratio: +29% (up=3, down=1)